Boothbay Fund Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,122
| Closed | -$30K | – | 2107 |
|
|
2022
Q1 | $30K | Hold |
6,122
| – | – | ﹤0.01% | 1835 |
|
|
2021
Q4 | $42K | Hold |
6,122
| – | – | ﹤0.01% | 1615 |
|
|
2021
Q3 | $189K | Sell |
6,122
-2,735
| -31% | -$84.4K | 0.01% | 1356 |
|
|
2021
Q2 | $288K | Sell |
8,857
-266
| -3% | -$8.65K | 0.01% | 1156 |
|
|
2021
Q1 | $345K | Buy |
+9,123
| New | +$345K | 0.01% | 924 |
|
|
2020
Q3 | – | Sell |
-5,300
| Closed | -$233K | – | 1000 |
|
|
2020
Q2 | $233K | Buy |
+5,300
| New | +$233K | 0.02% | 645 |
|
|
2018
Q3 | – | Sell |
-7,619
| Closed | -$667K | – | 721 |
|
|
2018
Q2 | $667K | Buy |
7,619
+4,332
| +132% | +$379K | 0.06% | 181 |
|
|
2018
Q1 | $636K | Buy |
+3,287
| New | +$636K | 0.08% | 194 |
|